Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4615-4623

  Haddad, Ramsi ^a   Held, William A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHROMOSOME 7; CHROMOSOME LOSS; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENOME IMPRINTING; LIVER CARCINOGENESIS; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; ANTIGENS, VIRAL, TUMOR; CHROMOSOME MAPPING; CROSSES, GENETIC; FEMALE; GENETIC MARKERS; GENOMIC IMPRINTING; GENOTYPE; INSULIN-LIKE GROWTH FACTOR II; LIVER; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, TRANSGENIC; PHENOTYPE; POLYMERASE CHAIN REACTION; SIMIAN VIRUS 40;

EID: 0030871047     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Held, W. A., Mullins, J. J., Kuhn, N. J., Gallagher, J. F., Gu, G. D., and Gross, K. W. T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene. EMBO J., 8: 183-191, 1989.
2. Schirmacher, P., Held, W. A., Yang, D., Biempica, L., and Rogler, C. E. Selective amplification of periportal transitional cells precedes formation of hepatocellular carcinoma in SV40 large Tag transgenic mice. Am. J. Pathol., 139: 231-241, 1991.
3. Christofori, G., and Hanahan, D. Molecular dissection of multistage tumorigenesis in transgenic mice. Cancer Biol., 5: 3-12, 1994.
4. Levine, D. S., Sanchez, C. A., Rabinovitch, P. S., and Reid, B. J. Formation of the tetraploid intermediate is associated with the development of cells with more than four centrioles in the elastase-simian virus 40 tumor antigen transgenic mouse model of pancreatic cancer. Proc. Natl. Acad. Sci. USA, 88: 6427-6431, 1991.
5. Rainier, S., Dobry, C. J., and Feinberg, A. P. Loss of imprinting in hepatoblastoma. Cancer Res., 55: 1836-1838, 1995.
6. Rainier, S., Johnson, L. A., Dobry, C. J., Ping, A. J., Crundy, P. E., and Feinberg, A. P. Relaxation of imprinted genes in human cancer. Nature (Lond.), 362: 747-749, 1993.
7. Pearsall, R. S., Shibata, H., Brozowska, A., Yoshino, K., Okuda, K., deJong, P. J., Plass, C., Chapman, V. M., Hayashizaki, Y., and Held, W. A. Absence of imprinting in U2AFBPL, a human homologue of the imprinted mouse gene U2afbp-rs. Biochem. Biophys. Res. Commun., 222: 171-177, 1996.
8. Held, W. A., Pazik, J., Giancola O'Brien, J., Kearns, K., Gobey, M., Meis, R., Kenny, L., and Rustum, Y. Genetic analysis of liver tumorigenesis in SV40 T antigen transgenic mice implies a role for imprinted genes. Cancer Res., 54: 6489-6495, 1994.
9. Schirmacher, P., Held, W. A., Yang, D., Chisari, F. V., Rustum, Y., and Rogler, C. E., Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res., 52: 2549-2556, 1992.
10. Casola, S., Ungaro, P., Pedone, P. V., Lazzaro, D., Fattori, E., Ciliberto, G., Zarrilli, R., Bruni, C. B., and Riccio, A. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas. Oncogene, 11: 711-721, 1995.
11. Zemel, S., Bartolomei, M., and Tilghman, S. Physical linkage of two mammalian imprinted genes. Nat. Genet., 2: 61-65, 1992.
12. De Chira, T. M., Robertson, E. J., and Efstratiadis, A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell, 64: 849-859, 1991.
13. Bartolomei, M. S., Zemel, S., and Tilghman, S. M. Parental imprinting of the mouse H19 gene. Nature (Lond.), 351: 153-155, 1991.
14. Hao, Y., Crenshaw, T., Moulton, T., Newcomb, E., and Tycko, B. Tumour-suppressor activity of H19 mRNA. Nature (Lond.), 365: 764-767, 1993.
15. Baker, J., Liu, J. P., Robertson, E. J., and Efstratiadis, A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75: 73-82, 1993.
16. Oka, Y., Rozek, L. M., and Czech, M. P. Direct demonstration of rapid insulin-like growth factor II receptor internalization and recycling in rat adipocytes. J. Biol. Chem., 260: 9435-9442, 1985.
17. Reik, W., Brown, K. W., Slatter, R. E., Sartori, P., Elliot, M., and Maher, E. R. Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndrome. Hum. Mol. Genet., 3: 1297-1301, 1994.
18. Weksberg, R., Shen, D. R., Fei, Y. L., Song, Q. L., and Squire, J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Weidemann syndrome. Nat. Genet., 5: 143-150, 1993.
19. Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., and Reeve, A. E. Relaxation of inulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (Lond.), 362: 749-751, 1993.
20. Davies, S. M. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Res., 53: 4781-4783, 1993.
21. Montagna, M., Menin, C., Chieco-Bianchi, L., and D'Andrea, E. Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. J. Cancer Res. Clin. Oncol., 120: 732-736, 1994.
22. Li, X., Adam, G., Cui, H., Sandstedt, B., Ohlsson, R., and Ekstrom, T. J. Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of IGF2 and H19 imprinting. Oncogene, 11: 221-229, 1995.
23. van Gurp, R. J., Oosterhuis, J. W., Kalscheuer, V., Mariaman, E. C., and Looijenga, L. H. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J. Natl. Cancer Inst., 86: 1070-1075, 1994.
24. McCann, A. H., Miller, N., O'Meara, A., Pedersen, I., Keogh, K., Gorey, T., and Dervan, P. A. Biallelic expression of the IGF2 gene in human breast disease. Human Molecular Genetics, 5: 1123-1127, 1996.
25. Christofori, G., Naik, P., and Hanahan, D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature (Lond.), 369: 414-417, 1994.
26. Christofori, G., Naik, P., and Hanahan, D. Deregulation of both imprinted and expressed alleles of the insulin-like growth factor 2 gene during beta-cell tumorigenesis. Nat. Genet., 10: 196-201, 1995.
27. De Chiara, T. M., Efstratiadis, A., and Robertson, E. J. A growth-deficiency pheno-type in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (Lond.), 345: 78-80, 1990.
28. Dietrich, W., Katz, H., Lincoln, S. E., Shin, H. S., Friedman, J., Dracopoli, N. C., and Lander, E. S. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics, 131: 423-447, 1992.
29. Freidman, J. M., Schneider, B. S., Barton, D. E., and Francke, U. Level of expression and chromosome mapping of the mouse cholecystokinin gene: implications for murine models of genetic obesity. Genomics, 5: 463-469, 1989.
30. Daniel, W. Biostatistics, a Foundation for Analysis in the Health Sciences, Ed. 6, pp. 507-529; 586-591. New York: John Wiley and Sons, Inc., 1995.
31. Saracci, R., and Repetto, F. Time trends of primary liver cancer: indication of increased incidence in selected cancer registry populations. J. Natl. Cancer Inst., 65: 241-247, 1980.
32. Kemp, C. J., Leary, C. N., and Drinkwater, N. R. Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proc. Natl. Acad. Sci. USA, 86: 7505-7509, 1989.
33. Leighton, P. A., Ingram, R. S., Eggenschwiler, J., Efstratiadis, A., and Tilghman, S. M. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature (Lond.), 375: 34-39, 1995.
34. Vu, T., and Hoffman, A. Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature (Lond.), 371: 714-717, 1994.
35. Ekstrom, T., Cui, H., Li, X., and Ohlsson, R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development (Camb.), 121: 309-316, 1995.
36. Guillemot, F., Caspary, T., Tilghman, S. M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Anderson, D. J., Joyner, A. L., Rossant, J., and Nagy, A. Genomic imprinting of Mash2, a mouse gene required for trophoblast development. Nat. Genet., 9: 235-241, 1995.
37. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9: 650-662, 1995.
38. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev., 9: 650-662, 1995.
39. KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat. Genet., 11: 204-206, 1995.
40. LaSalle, J. M., and Lalande, M. Domain organization of allele-specific replication within the GABRB3 gene cluster requires a biparental 11q11-13 contribution. Nat. Genet., 9: 386-394, 1995.
41. Tycko, B. Genomic imprinting: mechanism and role in human pathology. Am. J. Pathol., 144: 431-443, 1994.
42. Wevrick, R., Kerns, J. A., and Francke, U. Identification of a novel paternally expressed gene in the Prader-Willi syndrome region. Hum. Mol. Genet., 3: 1877-1882, 1994.
43. Kuroiwa, Y., Kaneko-Ishino, T., Kagitani, F., Kohda, T., Li, L., Tada, M., Suzuki, R., Yokoyama, M., Shiroishi, T., Wakana, S., Barton, S., Ishino, F., and Surani, M. Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein. Nat. Genet., 12: 186-190, 1996.
44. Naik, P., Karrim, J., and Hanahan, D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 10: 2105-2116, 1996.